Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Open-Label Trial to Evaluate PK, Safety, and Tolerability of TAK-664 in IG Treatment-Naïve Participants With Primary Immunodeficiency Diseases

NCT07794735 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT07794735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07794735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Open-Label Trial to Evaluate PK, Safety, and Tolerability of TAK-664 in IG Treatment-Naïve Participants With Primary Immunodeficiency Diseases
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
December 1, 2027
Enrollment
9 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiency diseases (pid)